L-3-Aminoisobutanoate (BioCAD00000012917)

blood feces urine

Metabolite Card

Formula: C4H9NO2 (103.0633)
SMILES: C[C@@H](CN)C(O)=O

Synonyms [en]

(S)-3-Amino-2-methylpropanoate; (S)-3-aminoisobutyric acid; (S)-3-Amino-isobutyric acid; (S)-beta-aminoisobutyrate; (S)-3-Amino-isobutanoic acid; L-3-Amino-isobutanoic acid

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

L-3-Aminoisobutanoate. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000012917). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

beta-Aminoisobutyric acid is a non-protein amino acid originating from the catabolism of thymine and valine. The concentration of beta-aminoisobutyric acid is normally low in urine as beta-aminoisobutyric acid is further catabolized by beta-aminoisobutyrate aminotransferases to methylmalonic acid semialdehyde and propionyl-CoA. beta-Aminoisobutyric acid occurs in two isomeric forms and both enantiomers of beta-aminoisobutyric acid can be detected in human urine and plasma. In plasma, the S-enantiomer is the predominant type due to active renal reabsorption. In contrast, urine almost exclusively contains the R-enantiomer of beta-aminoisobutyric acid, which is eliminated both by filtration and tubular secretion. Persistently increased levels of beta-aminoisobutyric acid have been observed in individuals with a deficiency of R (-)-beta-aminoisobutyrate-pyruvate aminotransferase. In addition, transient high levels of beta-aminoisobutyric acid have been observed under a variety of pathological conditions such as lead poisoning, starvation, in total body irradiation, and in a number of malignancies. The S-enantiomer of beta-aminoisobutyric acid is predominantly derived from the catabolism of valine. It has been suggested that altered homeostasis of beta-alanine underlies some of the clinical abnormalities encountered in patients with a dihydropyrimidine dehydrogenase (DPD) deficiency. DPD constitutes the first step of the pyrimidine degradation pathway, in which the pyrimidine bases uracil and thymine are catabolized to beta-alanine and the R-enantiomer of beta-aminoisobutyric acid respectively. In normal individuals with an intact pyrimidine degradation pathway, R-methylmalonic acid semialdehyde can be synthesized directly from the catabolism of thymine. Hence, there might be less cross-over between the valine and thymine pathway, allowing the conversion of S-methylmalonic acid semialdehyde into S-beta-aminoisobutyric acid and the subsequent accumulation of S-beta-aminoisobutyric acid in plasma (PMID: 14705962, 14292857, 14453202).

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 4249-19-8
  • PubChem: 439434
  • ChEBI: ChEBI:18188
  • ChEBI: ChEBI:33094
  • HMDB: HMDB0002166
  • LipidMaps: LMFA01100050
  • KEGG: C03284
  • BioCyc: CPD-466
  • DrugBank: DB03432
  • RefMet: RM0134977
  • Metlin: METLIN_45884

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R04187 2.6.1.18 L-alanine:3-oxopropanoate aminotransferase
KEGG:R04188 2.6.1.22 L-3-amino-isobutanoate:2-oxoglutarate aminotransferase
BioCyc:RXN-14265 2.6.1.- L-alanine-(S)-methylmalonate semialdehyde aminotransferase
BioCyc:2.6.1.22-RXN 2.6.1.22 2-KETOGLUTARATE + CPD-466<=>GLT + CH3-MALONATE-S-ALD
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
WikiPathways:WP3604 Biochemical pathways: part I
PathBank:SMP0120662 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I
PathBank:SMP0120806 3-Hydroxyisobutyric Aciduria
PathBank:SMP0120440 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency
PathBank:SMP0120444 3-Methylglutaconic Aciduria Type IV
PathBank:SMP0120516 Maple Syrup Urine Disease
PathBank:SMP0120589 Isovaleric Acidemia
PathBank:SMP0000032 Valine, Leucine, and Isoleucine Degradation
PathBank:SMP0000173 beta-Ketothiolase Deficiency
PathBank:SMP0000199 Maple Syrup Urine Disease
PathBank:SMP0000384 Methylmalonate Semialdehyde Dehydrogenase Deficiency
PathBank:SMP0000141 3-Methylglutaconic Aciduria Type IV
PathBank:SMP0000524 Isovaleric Acidemia
PathBank:SMP0087234 Valine, Leucine, and Isoleucine Degradation
PathBank:SMP0120661 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency
PathBank:SMP0120665 3-Methylglutaconic Aciduria Type IV
PathBank:SMP0120745 Methylmalonic Aciduria
PathBank:SMP0120757 Propionic Acidemia
PathBank:SMP0120805 3-Hydroxyisobutyric Acid Dehydrogenase Deficiency
PathBank:SMP0120439 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency
View All Pathways